BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia.
Smith AL, Skupa SA, Eiken AP, Reznicek TE, Schmitz E, Williams N, Moore DY, D'Angelo CR, Kallam A, Lunning MA, Bociek RG, Vose JM, Mohamed E, Mahr AR, Denton PW, Powell B, Bollag G, Rowley MJ, El-Gamal D.
Smith AL, et al. Among authors: skupa sa.
JCI Insight. 2024 May 22;9(10):e177054. doi: 10.1172/jci.insight.177054.
JCI Insight. 2024.
PMID: 38775157
Free PMC article.